High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients

Sara De Iudicibus, Marianna Lucafò, Nicola Vitulo, Stefano Martelossi, Rosanna Zimbello, Fabio De Pascale, Claudio Forcato, Samuele Naviglio, Alessia Di Silvestre, Marco Gerdol, Gabriele Stocco, Giorgio Valle, Alessandro Ventura, Matteo Bramuzzo, Giuliana Decorti

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The aim of this research was the identification of novel pharmacogenomic biomarkers for better understanding the complex gene regulation mechanisms underpinning glucocorticoid (GC) action in paediatric inflammatory bowel disease (IBD). This goal was achieved by evaluating high-throughput microRNA (miRNA) profiles during GC treatment, integrated with the assessment of expression changes in GC receptor (GR) heterocomplex genes. Furthermore, we tested the hypothesis that differentially expressed miRNAs could be directly regulated by GCs through investigating the presence of GC responsive elements (GREs) in their gene promoters. Ten IBD paediatric patients responding to GCs were enrolled. Peripheral blood was obtained at diagnosis (T0) and after four weeks of steroid treatment (T4). MicroRNA profiles were analyzed using next generation sequencing, and selected significantly differentially expressed miRNAs were validated by quantitative reverse transcription-polymerase chain reaction. In detail, 18 miRNAs were differentially expressed from T0 to T4, 16 of which were upregulated and 2 of which were downregulated. Out of these, three miRNAs (miR-144, miR-142, and miR-96) could putatively recognize the 3’UTR of the GR gene and three miRNAs (miR-363, miR-96, miR-142) contained GREs sequences, thereby potentially enabling direct regulation by the GR. In conclusion, we identified miRNAs differently expressed during GC treatment and miRNAs which could be directly regulated by GCs in blood cells of young IBD patients. These results could represent a first step towards their translation as pharmacogenomic biomarkers.

Original languageEnglish
Article number1399
JournalInternational Journal of Molecular Sciences
Volume19
Issue number5
DOIs
Publication statusPublished - May 8 2018

Fingerprint

glucocorticoids
Pediatrics
sequencing
MicroRNAs
Inflammatory Bowel Diseases
Glucocorticoids
Throughput
genes
Genes
biomarkers
Biomarkers
Blood
polymerase chain reaction
Pharmacogenetics
blood cells
steroids
gene expression
Polymerase chain reaction
Transcription
profiles

Keywords

  • Glucocorticoids
  • Inflammatory bowel disease
  • mRNA
  • Pediatric patients

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients. / De Iudicibus, Sara; Lucafò, Marianna; Vitulo, Nicola; Martelossi, Stefano; Zimbello, Rosanna; De Pascale, Fabio; Forcato, Claudio; Naviglio, Samuele; Di Silvestre, Alessia; Gerdol, Marco; Stocco, Gabriele; Valle, Giorgio; Ventura, Alessandro; Bramuzzo, Matteo; Decorti, Giuliana.

In: International Journal of Molecular Sciences, Vol. 19, No. 5, 1399, 08.05.2018.

Research output: Contribution to journalArticle

De Iudicibus, Sara ; Lucafò, Marianna ; Vitulo, Nicola ; Martelossi, Stefano ; Zimbello, Rosanna ; De Pascale, Fabio ; Forcato, Claudio ; Naviglio, Samuele ; Di Silvestre, Alessia ; Gerdol, Marco ; Stocco, Gabriele ; Valle, Giorgio ; Ventura, Alessandro ; Bramuzzo, Matteo ; Decorti, Giuliana. / High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients. In: International Journal of Molecular Sciences. 2018 ; Vol. 19, No. 5.
@article{eb572453974e4e70a35621cb9e52be33,
title = "High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients",
abstract = "The aim of this research was the identification of novel pharmacogenomic biomarkers for better understanding the complex gene regulation mechanisms underpinning glucocorticoid (GC) action in paediatric inflammatory bowel disease (IBD). This goal was achieved by evaluating high-throughput microRNA (miRNA) profiles during GC treatment, integrated with the assessment of expression changes in GC receptor (GR) heterocomplex genes. Furthermore, we tested the hypothesis that differentially expressed miRNAs could be directly regulated by GCs through investigating the presence of GC responsive elements (GREs) in their gene promoters. Ten IBD paediatric patients responding to GCs were enrolled. Peripheral blood was obtained at diagnosis (T0) and after four weeks of steroid treatment (T4). MicroRNA profiles were analyzed using next generation sequencing, and selected significantly differentially expressed miRNAs were validated by quantitative reverse transcription-polymerase chain reaction. In detail, 18 miRNAs were differentially expressed from T0 to T4, 16 of which were upregulated and 2 of which were downregulated. Out of these, three miRNAs (miR-144, miR-142, and miR-96) could putatively recognize the 3’UTR of the GR gene and three miRNAs (miR-363, miR-96, miR-142) contained GREs sequences, thereby potentially enabling direct regulation by the GR. In conclusion, we identified miRNAs differently expressed during GC treatment and miRNAs which could be directly regulated by GCs in blood cells of young IBD patients. These results could represent a first step towards their translation as pharmacogenomic biomarkers.",
keywords = "Glucocorticoids, Inflammatory bowel disease, mRNA, Pediatric patients",
author = "{De Iudicibus}, Sara and Marianna Lucaf{\`o} and Nicola Vitulo and Stefano Martelossi and Rosanna Zimbello and {De Pascale}, Fabio and Claudio Forcato and Samuele Naviglio and {Di Silvestre}, Alessia and Marco Gerdol and Gabriele Stocco and Giorgio Valle and Alessandro Ventura and Matteo Bramuzzo and Giuliana Decorti",
year = "2018",
month = "5",
day = "8",
doi = "10.3390/ijms19051399",
language = "English",
volume = "19",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "5",

}

TY - JOUR

T1 - High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients

AU - De Iudicibus, Sara

AU - Lucafò, Marianna

AU - Vitulo, Nicola

AU - Martelossi, Stefano

AU - Zimbello, Rosanna

AU - De Pascale, Fabio

AU - Forcato, Claudio

AU - Naviglio, Samuele

AU - Di Silvestre, Alessia

AU - Gerdol, Marco

AU - Stocco, Gabriele

AU - Valle, Giorgio

AU - Ventura, Alessandro

AU - Bramuzzo, Matteo

AU - Decorti, Giuliana

PY - 2018/5/8

Y1 - 2018/5/8

N2 - The aim of this research was the identification of novel pharmacogenomic biomarkers for better understanding the complex gene regulation mechanisms underpinning glucocorticoid (GC) action in paediatric inflammatory bowel disease (IBD). This goal was achieved by evaluating high-throughput microRNA (miRNA) profiles during GC treatment, integrated with the assessment of expression changes in GC receptor (GR) heterocomplex genes. Furthermore, we tested the hypothesis that differentially expressed miRNAs could be directly regulated by GCs through investigating the presence of GC responsive elements (GREs) in their gene promoters. Ten IBD paediatric patients responding to GCs were enrolled. Peripheral blood was obtained at diagnosis (T0) and after four weeks of steroid treatment (T4). MicroRNA profiles were analyzed using next generation sequencing, and selected significantly differentially expressed miRNAs were validated by quantitative reverse transcription-polymerase chain reaction. In detail, 18 miRNAs were differentially expressed from T0 to T4, 16 of which were upregulated and 2 of which were downregulated. Out of these, three miRNAs (miR-144, miR-142, and miR-96) could putatively recognize the 3’UTR of the GR gene and three miRNAs (miR-363, miR-96, miR-142) contained GREs sequences, thereby potentially enabling direct regulation by the GR. In conclusion, we identified miRNAs differently expressed during GC treatment and miRNAs which could be directly regulated by GCs in blood cells of young IBD patients. These results could represent a first step towards their translation as pharmacogenomic biomarkers.

AB - The aim of this research was the identification of novel pharmacogenomic biomarkers for better understanding the complex gene regulation mechanisms underpinning glucocorticoid (GC) action in paediatric inflammatory bowel disease (IBD). This goal was achieved by evaluating high-throughput microRNA (miRNA) profiles during GC treatment, integrated with the assessment of expression changes in GC receptor (GR) heterocomplex genes. Furthermore, we tested the hypothesis that differentially expressed miRNAs could be directly regulated by GCs through investigating the presence of GC responsive elements (GREs) in their gene promoters. Ten IBD paediatric patients responding to GCs were enrolled. Peripheral blood was obtained at diagnosis (T0) and after four weeks of steroid treatment (T4). MicroRNA profiles were analyzed using next generation sequencing, and selected significantly differentially expressed miRNAs were validated by quantitative reverse transcription-polymerase chain reaction. In detail, 18 miRNAs were differentially expressed from T0 to T4, 16 of which were upregulated and 2 of which were downregulated. Out of these, three miRNAs (miR-144, miR-142, and miR-96) could putatively recognize the 3’UTR of the GR gene and three miRNAs (miR-363, miR-96, miR-142) contained GREs sequences, thereby potentially enabling direct regulation by the GR. In conclusion, we identified miRNAs differently expressed during GC treatment and miRNAs which could be directly regulated by GCs in blood cells of young IBD patients. These results could represent a first step towards their translation as pharmacogenomic biomarkers.

KW - Glucocorticoids

KW - Inflammatory bowel disease

KW - mRNA

KW - Pediatric patients

UR - http://www.scopus.com/inward/record.url?scp=85046692278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046692278&partnerID=8YFLogxK

U2 - 10.3390/ijms19051399

DO - 10.3390/ijms19051399

M3 - Article

C2 - 29738455

AN - SCOPUS:85046692278

VL - 19

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 5

M1 - 1399

ER -